Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease

Gut

Volumn 67, Issue 5, 2018, Pages 892-902

  Grander, Christoph ^a   Adolph, Timon E ^a   Wieser, Verena ^a   Lowe, Patrick ^b   Wrzosek, Laura ^c   Gyongyosi, Benedek ^b   Ward, Doyle V ^b   Grabherr, Felix ^a   Gerner, Romana R ^a   Pfister, Alexandra ^a   Enrich, Barbara ^a   Ciocan, Dragos ^c,d,e   Macheiner, Sophie ^a   Mayr, Lisa ^a   Drach, Matthias ^f   Moser, Patrizia ^g   Moschen, Alexander R ^a   Perlemuter, Gabriel ^c,d,e   Szabo, Gyongyi ^b   Cassard, Anne Marie ^c,d   Tilg, Herbert ^a   more..

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c INSERM   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e HÔPITAL ANTOINE BÉCLÈRE   (France)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^g MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Akkermansia muciniphila; alcoholic liver disease; alcoholic steatohepatitis; gut barrier; intestinal microbiota

Indexed keywords

ALCOHOL; DNA 16S;

ADULT; AKKERMANSIA MUCINIPHILA; ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; DISEASE SEVERITY; DNA SEQUENCE; FATTY LIVER; FECES MICROFLORA; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; INTESTINE FLORA; LIVER INJURY; MIDDLE AGED; MOUSE; NEUTROPHIL CHEMOTAXIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; POPULATION ABUNDANCE; PRIORITY JOURNAL; TIGHT JUNCTION; WILD TYPE; AGED; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MICROBIOLOGY; PHYSIOLOGY; VERRUCOMICROBIA;

ADULT; AGED; ANIMALS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHANOL; FECES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; VERRUCOMICROBIA;

EID: 85026304227     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-313432     Document Type: Article

References (60)

1. WHO. Global status report on alcohol and health. 2014 http://apps.who.int/iris/bitstream/10665/112736/1/9789240692763-eng.pdf?ua=1.
2. Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol 2013;59:160-8.
3. Arvaniti V, D'Amico G, Fede G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010;139:1246-56.
4. Thursz MR, Richardson P, Allison M, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med 2015;372:1619-28.
5. Tilg H, Moschen AR, Kaneider NC. Pathways of liver injury in alcoholic liver disease. J Hepatol 2011;55:1159-61.
6. Macnaughtan J, Jalan R. Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis. Am J Gastroenterol 2015;110:1399-410.
7. Apte UM, Banerjee A, McRee R, et al. Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis. Toxicol Appl Pharmacol 2005;207:25-38.
8. Ramaiah SK, Jaeschke H. Hepatic neutrophil infiltration in the pathogenesis of alcohol-induced liver injury. Toxicol Mech Methods 2007;17:431-40.
9. Mathurin P, Deng QG, Keshavarzian A, et al. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 2000;32:1008-17.
10. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000;343:1467-76.
11. Yan AW, Fouts DE, Brandl J, et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 2011;53:96-105.
12. Fukui H, Brauner B, Bode JC, et al. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 1991;12:162-9.
13. Mutlu EA, Gillevet PM, Rangwala H, et al. Colonic microbiome is altered in alcoholism. Am J Physiol Gastrointest Liver Physiol 2012;302:G966-G978.
14. Yan AW, Schnabl B. Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World J Hepatol 2012;4:110-8.
15. Rao RK. Acetaldehyde-induced barrier disruption and paracellular permeability in Caco-2 cell monolayer. Methods Mol Biol 2008;447:171-83.
16. Gabbard SL, Lacy BE, Levine GM, et al. The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth. Dig Dis Sci 2014;59:638-44.
17. Adachi Y, Moore LE, Bradford BU, et al. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995;108:218-24.
18. Mutlu E, Keshavarzian A, Engen P, et al. Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res 2009;33:1836-46.
19. Canesso MCC, Lacerda NL, Ferreira CM, et al. Comparing the effects of acute alcohol consumption in germ-free and conventional mice: the role of the gut microbiota. BMC Microbiol 2014;14:240.
20. Llopis M, Cassard AM, Wrzosek L, et al. Intestinal Microbiota contributes to individual susceptibility to alcoholic liver disease. Gut 2016;65.
21. Leclercq S, Matamoros S, Cani PD, et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A 2014;111:E4485-93.
22. Derrien M, Vaughan EE, Plugge CM, et al. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 2004;54:1469-76.
23. Collado MC, Derrien M, Isolauri E, et al. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal Microbiota present in infants, adults, and the elderly. Appl Environ Microbiol 2007;73:7767-70.
24. Derrien M, Collado MC, Ben-Amor K, et al. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl Environ Microbiol 2008;74:1646-8.
25. Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 2013;110:9066-71.
26. Li J, Lin S, Vanhoutte PM, et al. Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe-/- Mice. Circulation 2016;133:2434-46.
27. Alcoholic liver disease: morphological manifestations. review by an international group. Lancet 1981;1:707-11.
28. Bertola A, Mathews S, Ki SH, et al. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc 2013;8:627-37.
29. Wieser V, Tymoszuk P, Adolph TE, et al. Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease. J Hepatol 2016;64.
30. Hartmann P, Chen P, Wang HJ, et al. Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice. Hepatology 2013;58:108-19.
31. Zarrinpar A, Chaix A, Yooseph S, et al. Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab 2014;20:1006-17.
32. Fadrosh DW, Ma B, Gajer P, et al. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome 2014;2:6.
33. Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 2013;10:996-8.
34. UTA X manual is available at [http://www.drive5.com/usearch/manual/cmd-utax.html].
35. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60.
36. Tomas J, Wrzosek L, Bouznad N, et al. Primocolonization is associated with colonic epithelial maturation during conventionalization. Faseb J 2013;27:645-55.
37. Bull-Otterson L, Feng W, Kirpich I, et al. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS One 2013;8:e53028.
38. Hauge T, Persson J, Danielsson D. Mucosal bacterial growth in the upper gastrointestinal tract in alcoholics (heavy drinkers). Digestion 1997;58:591-5.
39. Naveau S, Essoh BM, Ghinoiu M, et al. Comparison of Fibrotest and PGAA for the diagnosis of fibrosis stage in patients with alcoholic liver disease. Eur J Gastroenterol Hepatol 2014;26:404-11.
40. Shin NR, Lee JC, Lee HY, et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014;63:727-35.
41. Keshavarzian A, Fields JZ, Vaeth J, et al. The differing effects of acute and chronic alcohol on gastric and intestinal permeability. Am J Gastroenterol 1994;89:2205-11.
42. Keshavarzian A, Holmes EW, Patel M, et al. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol 1999;94:200-7.
43. Ferrier L, Bérard F, Debrauwer L, et al. Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am J Pathol 2006;168:1148-54.
44. Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut Microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009;58:1091-103.
45. Farquhar MG, Palade GE. Junctional complexes in various epithelia. J Cell Biol 1963;17:375-412.
46. Ma TY, Nguyen D, Bui V, et al. Ethanol modulation of intestinal epithelial tight junction barrier. Am J Physiol 1999;276:G965-74.
47. Tilg H, Cani PD, Mayer EA. Gut microbiome and liver diseases. Gut 2016;65:2035-44.
48. Wang L, Fouts DE, Stärkel P, et al. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing Mucosa-Associated Microbiota and preventing bacterial translocation. Cell Host Microbe 2016;19:227-39.
49. Kabeerdoss J, Sankaran V, Pugazhendhi S, et al. Clostridium leptum group bacteria abundance and diversity in the fecal Microbiota of patients with inflammatory bowel disease: a case-control study in India. BMC Gastroenterol 2013;13:20.
50. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an antiinflammatory commensal bacterium identified by gut Microbiota analysis of crohn disease patients. Proc Natl Acad Sci U S A 2008;105:16731-6.
51. Greer RL, Dong X, Moraes AC, et al. Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism. Nat Commun 2016;7:13329.
52. Plovier H, Everard A, Druart C, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med 2017;23:107-13.
53. Dao MC, Everard A, Aron-Wisnewsky J, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 2016;65:426-36.
54. Shen J, Tong X, Sud N, et al. Low-Density lipoprotein receptor signaling mediates the Triglyceride-Lowering Action of Akkermansia muciniphila in Genetic-Induced hyperlipidemia. Arterioscler Thromb Vasc Biol 2016; 36:1448-56.
55. Neyrinck AM, Etxeberria U, Taminiau B, et al. Rhubarb extract prevents hepatic inflammation induced by acute alcohol intake, an effect related to the modulation of the gut Microbiota. Mol Nutr Food Res 2017;61.
56. Barone R, Rappa F, Macaluso F, et al. Alcoholic liver disease: a mouse Model reveals protection by Lactobacillus fermentum. Clin Transl Gastroenterol 2016;7:e138.
57. Chen RC, Xu LM, Du SJ, et al. Lactobacillus rhamnosus GG supernatant promotes intestinal barrier function, balances Treg and TH17 cells and ameliorates hepatic injury in a mouse model of chronic-binge alcohol feeding. Toxicol Lett 2016;241:103-10.
58. Forsyth CB, Farhadi A, Jakate SM, et al. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 2009;43:163-72.
59. Stadlbauer V, Mookerjee RP, Hodges S, et al. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol 2008;48:945-51.
60. Tilg H, Moschen AR, Szabo G. Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology 2016;64:955-65.